Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT088 subcutaneous vs intramuscular prophylaxis after liver transplantation
2005-003737-40Phase 3Completed
- Sponsor
- Biotest AG
- Start
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hepatitis B immune globulin in hepatitis B (HBV) (2 arms), sponsored by Biotest AG. Primary endpoint: Primary efficacy and safety endpoint. Started Dec 2005; status: completed.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2005-003737-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003737-40.